Feng Peng

5.0k total citations · 1 hit paper
95 papers, 3.1k citations indexed

About

Feng Peng is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feng Peng has authored 95 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 27 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feng Peng's work include Catalytic C–H Functionalization Methods (16 papers), Lung Cancer Treatments and Mutations (12 papers) and Synthetic Organic Chemistry Methods (10 papers). Feng Peng is often cited by papers focused on Catalytic C–H Functionalization Methods (16 papers), Lung Cancer Treatments and Mutations (12 papers) and Synthetic Organic Chemistry Methods (10 papers). Feng Peng collaborates with scholars based in China, United States and Canada. Feng Peng's co-authors include Ning Jiao, Samuel J. Danishefsky, Yu‐Feng Liang, Dennis G. Hall, Chun Zhang, Yuxin Cui, Michael Shevlin, Jacob H. Waldman, Yong‐Li Zhong and Alan M. Hyde and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Feng Peng

90 papers receiving 3.1k citations

Hit Papers

General Principles and Strategies for Salting-Out Informe... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Peng China 28 1.8k 726 295 286 285 95 3.1k
Jitender Bariwal India 24 2.5k 1.4× 830 1.1× 249 0.8× 117 0.4× 157 0.6× 49 3.3k
Rachid Benhida France 34 1.4k 0.8× 1.5k 2.0× 135 0.5× 249 0.9× 270 0.9× 183 3.4k
Susmita Mondal India 29 1.2k 0.7× 612 0.8× 144 0.5× 197 0.7× 139 0.5× 101 2.4k
Chao Li China 27 1.6k 0.9× 897 1.2× 306 1.0× 372 1.3× 477 1.7× 147 3.3k
Xiaoxing Wu China 26 834 0.5× 547 0.8× 154 0.5× 201 0.7× 115 0.4× 71 2.2k
Jacob Westman Sweden 16 2.3k 1.3× 1.2k 1.6× 208 0.7× 260 0.9× 392 1.4× 32 3.5k
Li Liu China 30 969 0.5× 1.1k 1.5× 96 0.3× 384 1.3× 179 0.6× 142 2.6k
Pralay Das India 33 2.0k 1.1× 777 1.1× 640 2.2× 410 1.4× 337 1.2× 151 3.1k
Rajesh K. Singh India 22 1.3k 0.7× 772 1.1× 94 0.3× 197 0.7× 131 0.5× 152 2.6k

Countries citing papers authored by Feng Peng

Since Specialization
Citations

This map shows the geographic impact of Feng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Peng more than expected).

Fields of papers citing papers by Feng Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Peng. The network helps show where Feng Peng may publish in the future.

Co-authorship network of co-authors of Feng Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Peng. A scholar is included among the top collaborators of Feng Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Peng. Feng Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Xinyan, Pengfei Zhou, Jun Guo, et al.. (2025). Harnessing tunable lignin-based carbon quantum dots for sustainable water purification. Green Energy & Environment. 11(2). 531–544.
2.
Tang, Yi‐Quan, Songmin Shang, Jiyou Yang, et al.. (2025). Synthesis and application of biomass-based carbon dots in deep eutectic solvent systems. Industrial Crops and Products. 224. 120440–120440. 8 indexed citations
3.
Dai, Yaomin, Qiang Xia, Zijun Mao, et al.. (2025). Sustainable bioplastics build on d -xylose cores: from backup to the center stage. Green Chemistry. 27(17). 4464–4488. 3 indexed citations
4.
Deng, Yuyang, et al.. (2024). Stall prediction model based on deep learning network in axial flow compressor. Chinese Journal of Aeronautics. 38(4). 103324–103324.
5.
Maddess, Matthew L., Ed Cleator, Mariko Morimoto, et al.. (2024). Process Development of a Tricyclic Diazepine-Based IDH1 Mutant Inhibitor. Organic Process Research & Development. 28(6). 2343–2354. 2 indexed citations
6.
Petrone, David A., Damien Valette, Justin A. Newman, et al.. (2024). HTE-Enabled Development of an Ene-Reductase-Catalyzed Desymmetrization: Remote Control of All-Carbon Quaternary γ-Centers. Organic Letters. 26(51). 11212–11217. 1 indexed citations
8.
Turnbull, Ben W. H., Feng Peng, Andrew J. Neel, et al.. (2023). Development of a Kilogram-Scale Synthesis of a Key Ulevostinag Subunit Part I: Accessing a Keto-Nucleoside Intermediate from Guanosine. Organic Process Research & Development. 27(3). 448–457. 2 indexed citations
9.
10.
Poirier, Marc, Zhijian Liu, Feng Peng, et al.. (2022). pH-Switchable Phase-Transfer Agents for Host Cell Protein Rejection in the Cascaded Biocatalytic Synthesis of an Active Pharmaceutical Ingredient. Organic Process Research & Development. 27(1). 179–188. 5 indexed citations
11.
Neel, Andrew J., Ben W. H. Turnbull, William Carson, et al.. (2022). A Unified Strategy to Fluorinated Nucleoside Analogues Via an Electrophilic Manifold. Organic Letters. 24(41). 7701–7706. 5 indexed citations
12.
Bottecchia, Cecilia, François Lévesque, Jonathan P. McMullen, et al.. (2021). Manufacturing Process Development for Belzutifan, Part 2: A Continuous Flow Visible-Light-Induced Benzylic Bromination. Organic Process Research & Development. 26(3). 516–524. 68 indexed citations
13.
Kim, Jungchul, Feng Xu, Zachary E. X. Dance, et al.. (2021). Development of a Practical Manufacturing Process to Relebactam via Thorough Understanding of the Origin and Control of Oligomeric Impurities. Organic Process Research & Development. 25(10). 2249–2259. 3 indexed citations
14.
Zhang, Yan, Huimin Chen, Yongmei Liu, et al.. (2019). Significant benefits of osimertinib in treating acquired resistance to first-generation EGFR-TKIs in lung squamous cell cancer: A case report. World Journal of Clinical Cases. 7(10). 1221–1229. 2 indexed citations
15.
Yu, Min, Qian Zhao, Yanying Li, et al.. (2018). Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. 33(10). 421–426. 6 indexed citations
16.
Hyde, Alan M., Susan L. Zultanski, Jacob H. Waldman, et al.. (2017). General Principles and Strategies for Salting-Out Informed by the Hofmeister Series. Organic Process Research & Development. 21(9). 1355–1370. 373 indexed citations breakdown →
17.
Wu, Yalan, Ruizhan Tong, Yan Zhang, et al.. (2017). Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC. OncoTargets and Therapy. Volume 10. 3307–3312. 10 indexed citations
18.
Wang, Chunting, Peng Zhang, Yongsheng Wang, et al.. (2009). RNA interference against Biot2, a novel mouse testis — specific gene, inhibits the growth of tumor cells. Cellular & Molecular Biology Letters. 14(3). 363–76. 3 indexed citations
19.
Yang, Hanshuo, Chunting Wang, Rui Wang, et al.. (2009). Characterization of a novel rat gene RTAP2a, screened by cross-reactive SEREX, restrictedly expressed in testis. Journal of Bioscience and Bioengineering. 107(6). 589–595. 3 indexed citations
20.
Lü, You, Yuquan Wei, Ling Tian, et al.. (2003). Immunogene Therapy of Tumors with Vaccine Based on Xenogeneic Epidermal Growth Factor Receptor. The Journal of Immunology. 170(6). 3162–3170. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026